370 related articles for article (PubMed ID: 16219903)
1. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
Louie SG; Sclar DA; Gill MA
Ann Pharmacother; 2005 Nov; 39(11):1861-9. PubMed ID: 16219903
[TBL] [Abstract][Full Text] [Related]
2. Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency.
Tirado-Conde G; Lara B; Miravitlles M
Ther Adv Respir Dis; 2008 Feb; 2(1):13-21. PubMed ID: 19124355
[TBL] [Abstract][Full Text] [Related]
3. Comment: comparisons of Aralast and Prolastin, alpha1-protease inhibitors for treatment of alpha1-antitrypsin deficiency.
Petteway SR
Ann Pharmacother; 2006 Feb; 40(2):353-4; author reply 354. PubMed ID: 16449545
[No Abstract] [Full Text] [Related]
4. Comment: Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
Gemberling JH; Finnerty MA
Ann Pharmacother; 2006 Apr; 40(4):786-7. PubMed ID: 16537818
[No Abstract] [Full Text] [Related]
5. Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy.
Barros-Tizón JC; Torres ML; Blanco I; Martínez MT;
Ther Adv Respir Dis; 2012 Apr; 6(2):67-78. PubMed ID: 22354900
[TBL] [Abstract][Full Text] [Related]
6. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
Tonelli AR; Brantly ML
Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
[TBL] [Abstract][Full Text] [Related]
7. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.
Mordwinkin NM; Louie SG
Expert Opin Pharmacother; 2007 Oct; 8(15):2609-14. PubMed ID: 17931094
[TBL] [Abstract][Full Text] [Related]
8. Alpha 1-antitrypsin augmentation therapy.
Sandhaus RA
Agents Actions Suppl; 1993; 42():97-102. PubMed ID: 8356934
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?
Modrykamien A; Stoller JK
Expert Opin Pharmacother; 2009 Nov; 10(16):2653-61. PubMed ID: 19827990
[TBL] [Abstract][Full Text] [Related]
10. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.
Bull World Health Organ; 1997; 75(5):397-415. PubMed ID: 9447774
[TBL] [Abstract][Full Text] [Related]
11. A pilot study comparing the purity, functionality and isoform composition of alpha-1-proteinase inhibitor (human) products.
Cowden DI; Fisher GE; Weeks RL
Curr Med Res Opin; 2005 Jun; 21(6):877-83. PubMed ID: 15969888
[TBL] [Abstract][Full Text] [Related]
12. Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release.
Nita I; Hollander C; Westin U; Janciauskiene SM
Respir Res; 2005 Jan; 6(1):12. PubMed ID: 15683545
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1-antitrypsin replacement therapy: current status.
Abusriwil H; Stockley RA
Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
[TBL] [Abstract][Full Text] [Related]
14. The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.
Schmid ST; Koepke J; Dresel M; Hattesohl A; Frenzel E; Perez J; Lomas DA; Miranda E; Greulich T; Noeske S; Wencker M; Teschler H; Vogelmeier C; Janciauskiene S; Koczulla AR
Int J Chron Obstruct Pulmon Dis; 2012; 7():687-96. PubMed ID: 23055718
[TBL] [Abstract][Full Text] [Related]
15. A review of alpha-1 antitrypsin deficiency.
Ranes J; Stoller JK
Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
[TBL] [Abstract][Full Text] [Related]
16. Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin.
Stoller JK; Rouhani F; Brantly M; Shahin S; Dweik RA; Stocks JM; Clausen J; Campbell E; Norton F
Chest; 2002 Jul; 122(1):66-74. PubMed ID: 12114340
[TBL] [Abstract][Full Text] [Related]
17. Alpha-1 antitrypsin augmentation therapy.
Wewers MD; Crystal RG
COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
[TBL] [Abstract][Full Text] [Related]
18. Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy.
Zamora NP; Pla RV; Del Rio PG; Margaleff RJ; Frias FR; Ronsano JB
Ann Pharmacother; 2008 May; 42(5):640-6. PubMed ID: 18413692
[TBL] [Abstract][Full Text] [Related]
19. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
Abboud RT; Ford GT; Chapman KR
Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
[TBL] [Abstract][Full Text] [Related]
20. Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency.
Blanco I; Canto H; de Serres FJ; Fernandez-Bustillo E; Rodríguez MC
J Rheumatol; 2004 Oct; 31(10):2082-5. PubMed ID: 15468381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
